NASDAQ:ACRS - Aclaris Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$5.97 -0.15 (-2.45 %)
(As of 03/25/2019 12:58 PM ET)
Previous Close$6.12
Today's Range$5.75 - $6.09
52-Week Range$5.49 - $21.97
Volume359,632 shs
Average Volume661,814 shs
Market Capitalization$246.38 million
P/E Ratio-1.48
Dividend YieldN/A
Beta1.24

Analyst Ratings

Aclaris Therapeutics (NASDAQ:ACRS) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Aclaris Therapeutics in the last 12 months. Their average twelve-month price target is $45.3333, suggesting that the stock has a possible upside of 659.35%. The high price target for ACRS is $52.00 and the low price target for ACRS is $34.00. There are currently 3 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 3.003.003.003.00
Ratings Breakdown: 0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $45.3333$45.3333$47.25$51.6667
Price Target Upside: 659.35% upside520.16% upside574.04% upside205.00% upside

Aclaris Therapeutics (NASDAQ:ACRS) Consensus Price Target History

Price Target History for Aclaris Therapeutics (NASDAQ:ACRS)

Aclaris Therapeutics (NASDAQ:ACRS) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/22/2019Cantor FitzgeraldReiterated RatingBuy$50.00LowView Rating Details
10/16/2018JMP SecuritiesLower Price TargetMarket Perform ➝ Buy$47.00 ➝ $34.00HighView Rating Details
3/28/2018Leerink SwannLower Price TargetOutperform ➝ Outperform$54.00 ➝ $52.00LowView Rating Details
2/8/2018GuggenheimInitiated CoverageBuy ➝ Buy$53.00MediumView Rating Details
7/31/2017Jefferies Financial GroupReiterated RatingBuy$36.00HighView Rating Details
(Data available from 3/25/2017 forward)
This page was last updated on 3/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel